Close Menu

NEW YORK — Evonetix said on Wednesday that it has extended its partnership with semiconductor firm Analog Devices to develop new DNA synthesis products.

Under the terms of the deal, the companies will collaborate on the development and commercial scaleup of Evonetix's proprietary microelectromechanical systems (MEMS)-based silicon chips, which are designed to synthesize DNA within thousands of independently controlled reaction sites.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.